Background illustration for clinical trials search

Paid Clinical Trials Oregon

Discover 1,087 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: St. John's, Westbrook ME, Boston MA, Quebec, Sherbrooke,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06966700

Phase 3, Recruiting

K-ORCA: Testing a Decision Support Tool and Group Process for Selecting Interventions

for
Child Abuse, Decision Making, Child Welfare,
Location: Eugene OR
Sponsor: Chestnut Health Systems

Sex: All

Age: 18+

Code: NCT06375551

Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06943755

Phase 2, Phase 3, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: St. John's, Scarborough ME, Boston MA, Providence RI,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Boston MA, The Bronx NY, New York NY, Hershey PA,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06731478

Phase 3, Recruiting

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

for
Parkinson Disease,
Location: Tempe AZ, Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 50 - 70+

Code: NCT06815302

Recruiting

Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia

for
Atypical Chronic Myeloid Leukemia,
Location: Columbus OH, Portland OR
Sponsor: Uma Borate

Sex: All

Age: 18+

Code: NCT06523556

Phase 1, Phase 2, Recruiting

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Springfield MA, Westbury NY, New York NY, Bloomfield NJ,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT07064759

Phase 3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Boston MA, Westbury NY, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase 2, Recruiting

STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners

for
Frontotemporal Dementia, Caregiver Burden,
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 70+

Code: NCT06613204

Recruiting

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

for
Breast Cancer
Location: Boston MA, East Patchogue NY, The Bronx NY,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07100106

Phase 1, Phase 2, Recruiting

Quantification & Classification of Inflammatory Cells in Uveitis Using OCT

for
Anterior Uveitis (AU), Birdshot Chorioretinitis, Behcet Disease,
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 5 - 70+

Code: NCT07065747

Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Boston MA, Quebec, Greenfield Park, Montreal, Miami FL,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase 2, Recruiting

FiberLocker® System Augmentation of Rotator Cuff Repairs

for
Rotator Cuff Tear, Rotator Cuff Tears,
Location: Columbia MD, Winston-Salem NC, Chicago IL, Medford OR
Sponsor: ZuriMED Technologies Inc.

Sex: All

Age: 30 - 70

Code: NCT06918041

Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

for
Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS),
Location: Boston MA, New York NY, Chapel Hill NC, Columbus OH,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT06465953

Phase 3, Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Foxborough MA, Burlington MA, Levis, Teaneck NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase 3, Recruiting

Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

for
Middle Schools, School Exclusion, School Community,
Location: Salem OR, Yuba City CA, Capitola CA
Sponsor: University of Oregon

Sex: All

Age: 8 - 15

Code: NCT06292078

Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Plymouth MA, Astoria NY, The Bronx NY, New York NY,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase 2, Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Boston MA, New York NY, Charlottesville VA,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 18 - 66

Code: NCT06859424

Phase 2, Recruiting

Popular cities in Oregon